Exercise, Aerobic
6
0
1
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
16.7%
1 terminated out of 6 trials
50.0%
-36.5% vs benchmark
17%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Aerobic Exercise is Cardio-protective in Hemato-oncological Disease and New-onset Chemotherapy
Pedaling at a Low-Moderate Intensity During Chemotherapy Administration
Low-moderate Intensity Pedaling During Immunotherapy Administration
The Effect of Bicycle Ergometer Training on Balance and Emg Activity
Interfaces of Non-invasive Ventilation on Performance in Patients With Chronic Obstructive Pulmonary Disease
Effect of the Inhibition of the Mammalian Target of Rapamycin on Metabolism and Exercise